Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia

Published:2021-05-03 Issue:1 Volume:194 Page:28-43
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Pocock Rachael¹^ORCID,Farah Nadine¹^ORCID,Richardson Simon E.²³^ORCID,Mansour Marc R.¹^ORCID

Affiliation:

1. Department of Haematology UCL Cancer InstituteUniversity College London LondonUK

2. Wellcome‐MRC Cambridge Stem Cell InstituteUniversity of Cambridge CambridgeUK

3. Department of Haematology University of CambridgeJeffrey Cheah Biomedical Centre Cambridge UK

Funder

Kay Kendall Leukaemia Fund

Cancer Research UK

Wellcome Trust

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17310

Reference124 articles.

1. Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

2. Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

3. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

4. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

5. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of ALL in adults: 2024 ELN recommendations from a European expert panel;Blood;2024-05-09

2. CD7 Nanobody-Based Immuno-Nanotoxin for Targeted Treatment of T-Cell Acute Lymphoblastic Leukemia;ACS Applied Nano Materials;2024-03-21

3. An Anti-CD7 Antibody–Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL);Biomolecules;2024-01-15

4. The role and mechanism of AZD5363 anti-leukemia activity in T-cell acute lymphoblastic leukemia;European Journal of Pharmacology;2024-01

5. Role of DNA Damage Response in Cancer and Healthy Stem Cells: Genome Stability, Tumor Development and Drug Resistance;Comprehensive Hematology and Stem Cell Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3